Preliminary studies indicate that this peptide – a dual activator of gut hormone and GIP receptors – presents a significant improvement in metabolic management programs . In contrast to existing treatments , the peptide seems to influence food intake and metabolic expenditure via multiple mechanisms . Despite additional investigation is require